Back to Search
BARBARA KIRCHER, M.D.
M.D.
Cardiovascular Disease Physician
NPI: 1346276896Individual
Specialties, Licenses & Credentials
Cardiovascular Disease PhysicianPrimary
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
242007(NY)
Research & Publications (20)
Anti-leukemic activity of valproic acid and imatinib mesylate on human Ph+ ALL and CML cells in vitro.
PMID 19226363·Eur J Haematol·2009
8-other
Modulation of the biological properties of aspirin by formation of a bioorganometallic derivative.
PMID 19115335·Angew Chem Int Ed Engl·2009
7-preclinical
HLA-A*0201 is associated with a better outcome after donor lymphocyte infusion for recurrent malignancy.
PMID 18801059·Eur J Haematol·2009
8-other
T-cell precursor frequencies and long-term outcome following unrelated hematopoietic stem cell transplantation.
PMID 18522713·Int J Lab Hematol·2008
8-other
Biological effect of mono- and dinuclear alkylamine platinum(II) compounds on human lymphoma cells.
PMID 18078673·J Inorg Biochem·2008
8-other
Vascular endothelial growth factor and activin-a serum levels following allogeneic hematopoietic stem cell transplantation.
PMID 17640598·Biol Blood Marrow Transplant·2007
8-other
Phenotype frequencies of autosomal minor histocompatibility antigens display significant differences among populations.
PMID 17604453·PLoS Genet·2007
4-observational
Impact of natural killer cell dose and donor killer-cell immunoglobulin-like receptor (KIR) genotype on outcome following human leucocyte antigen-identical haematopoietic stem cell transplantation.
PMID 17493020·Clin Exp Immunol·2007
8-other
Elevated levels of serum CD44 and E-cadherin predict an unfavourable outcome in myelodysplastic syndromes.
PMID 16990777·Leukemia·2006
8-other
Synergistic and additive antiproliferative effects on human leukemia cell lines induced by combining acetylenehexacarbonyldicobalt complexes with the tyrosine kinase inhibitor imatinib.
PMID 16908070·J Inorg Biochem·2006
8-other
Donor cytomegalovirus seropositivity and the risk of leukemic relapse after reduced-intensity transplants.
PMID 16480430·Eur J Haematol·2006
4-observational
Dendritic cells in allogeneic hematopoietic stem cell transplantation.
PMID 16194884·Leuk Lymphoma·2005
6-review
Synthesis and pharmacological evaluation of 1H-imidazoles as ligands for the estrogen receptor and cytotoxic inhibitors of the cyclooxygenase.
PMID 16190777·J Med Chem·2005
8-other
Antitumor-active cobalt-alkyne complexes derived from acetylsalicylic acid: studies on the mode of drug action.
PMID 15658875·J Med Chem·2005
8-other
Towards functional transplant donor matching by measurement of granzyme A and granzyme B production levels.
PMID 15541276·J Immunol Methods·2004
8-other
Substituted pyridazino[3,4-b][1,5]benzoxazepin-5(6H)ones as multidrug-resistance modulating agents.
PMID 15317472·J Med Chem·2004
8-other
No predictive value of cytotoxic or helper T-cell precursor frequencies for outcome when analyzed from the graft after stem cell transplantation.
PMID 15170521·Ann Hematol·2004
8-other
Investigations on the effects of cobalt-alkyne complexes on leukemia and lymphoma cells: cytotoxicity and cellular uptake.
PMID 14987849·J Inorg Biochem·2004
8-other
The neuropeptide secretoneurin acts as a direct angiogenic cytokine in vitro and in vivo.
PMID 14970115·Circulation·2004
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1000 E GENESEE ST, SUITE 300
SYRACUSE, NY 13210 - Phone
- (315) 471-1044
Quick Facts
- NPI
- 1346276896
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile